Gene therapy for inherited high cholesterol
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests a new gene therapy called NGGT006 for people with a genetic form of high cholesterol that doesn't improve with standard treatments. It aims to lower cholesterol levels and reduce the risk of heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You have a genetic form of high cholesterol confirmed by a blood test.
- You have been on the highest dose of cholesterol-lowering medicines for at least 4 weeks, but your cholesterol is still high.
- You have been following a healthy diet for at least 12 weeks and can keep it up during the trial.
- You have not had a heart attack or stroke in the last 6 months.
- You are willing to use effective birth control for at least a year after the treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new gene therapy called YOLT-101 for people with familial hypercholesterolemia, a genetic condition that causes very high cholesterol. The treatment aims to lower cholesterol levels and reduce heart risks.
This trial tests an experimental treatment that uses tiny particles to deliver a genetic message to help lower very high cholesterol caused by a rare inherited condition. It may offer a new option for people who have not responded to standard treatments.
This trial tests a one-time gene therapy to lower extremely high cholesterol in people with a rare inherited condition. It may help reduce heart attack risk in those who haven't responded to standard treatments.
This study tests a new injection called ART002g1 for people with an inherited form of high cholesterol (heterozygous familial hypercholesterolemia). The goal is to see if it is safe and can help lower cholesterol levels.
This trial tests an experimental medicine called VERVE-102 to lower cholesterol in people with or at high risk for heart disease. It may help reduce the risk of heart attacks and strokes by targeting a gene that affects cholesterol levels.
This study tests an investigational medicine called QLC7401 for people with a genetic condition called heterozygous familial hypercholesterolemia, which causes very high cholesterol. It aims to see if the new medicine can further lower bad cholesterol when added to your usual cholesterol treatments.
Hear when a new Familial Hypercholesterolemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.